Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 101–200 of 888
Zhao, J., Zhao, J., Van Rooijen, N., & Perlman, S. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000636 · Cited by 152
Tomei, A. A., Siegert, S., Britschgi, M. R., Luther, S. A., & Swartz, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900835 · Cited by 150
Development, trafficking, and function of memory T‐cell subsets
Lefrançois, L. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00393.x · Cited by 151
Strategies of Tumor Immune Evasion
Seliger, B. (2005) · BioDrugs · doi:10.2165/00063030-200519060-00002 · Cited by 176
van Montfoort, N., Camps, M. G. M., Khan, S., Filippov, D. V., Weterings, J. J., Griffith, J. M., Geuze, H. J., van Hall, T., Verbeek, J. S., Melief, C. J. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900969106 · Cited by 151
“This migration time has been estimated to last 24–48 h (31, 32).”
BackgroundBrandum, E. P., Jørgensen, A. S., ROSENKILDE, M. M., & Hjortø, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158340 · Cited by 168
“BALT, bronchus-associated lymphoid tissue, is a type of MALT formed within the lungs with organized lymphoid structures with HEVs and B- and T-cell areas, which occurs as a response to pulmonary inflammation [63].”
BackgroundArdavín, C., Amigorena, S., & Sousa, C. R. E. (2004) · Immunity · doi:10.1016/s1074-7613(03)00352-2 · Cited by 149
Immunoregulation of Dendritic Cells
Wallet, M. A., Sen, P., & Tisch, R. (2005) · Clinical Medicine & Research · doi:10.3121/cmr.3.3.166 · Cited by 146
Instructive cytokine signals in dendritic cell lineage commitment
Schmid, M. A., Kingston, D., Boddupalli, S., & Manz, M. G. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00877.x · Cited by 133
Shelburne, C. P., Nakano, H., St. John, A. L., Chan, C., McLachlan, J. B., Gunn, M. D., Staats, H. F., & Abraham, S. N. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.004 · Cited by 139
“DC accumulation in DLNs is closely associated with a massive influx of naïve lymphocytes, a response that is functionally associated with optimal T-cell dependent immune responses (MartIn-Fontecha et al., 2003).”
BackgroundNLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells
Eisenbarth, S. C., Williams, A., Colegio, O. R., Meng, H., Strowig, T., Rongvaux, A., Henao-Mejia, J., Thaiss, C. A., Joly, S., Gonzalez, D. G., et al. (2012) · Nature · doi:10.1038/nature11012 · Cited by 134
“DC relocalization requires numerous integrated steps including emigration from the initial site of residence, the ability to home towards a chemokine gradient, transmigration through the lymphatic endothelial layer and the physical machinery to do so 15,24–26 .”
Yang, C.-Y., Vogt, T. K., Favre, S., Scarpellino, L., Huang, H.-Y., Tacchini-Cottier, F., & Luther, S. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312585111 · Cited by 139
“Migratory DCs are known to transmit antigen and inflammatory signals to LNs and thereby start the swelling process (14, 26).”
BackgroundLymphotoxin signalling in immune homeostasis and the control of microorganisms
Upadhyay, V., & Fu, Y.-X. (2013) · Nature Reviews Immunology · doi:10.1038/nri3406 · Cited by 138
T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node
Baratin, M., Simon, L., Jorquera, A., Ghigo, C., Dembélé, D., Nowak, J., Gentek, R., Wienert, S., Klauschen, F., MALISSEN, B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.019 · Cited by 147
“As previously reported, injected DCs migrated to the T cell zone of the draining LNs and began to disappear 72 hr later (Figure 4F) (MartIn-Fontecha et al., 2003).”
Fibroblast-Type Reticular Stromal Cells Regulate the Lymph Node Vasculature
Chyou, S., Ekland, E. H., Carpenter, A. C., Tzeng, T.-C. J., Tian, S., Michaud, M., Madri, J. A., & Lu, T. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3887 · Cited by 131
“Reduced blood vascular endothelial cell numbers may lead to reduced cellularity by reducing metabolic support, and reduced lymphatic endothelial cell numbers may contribute to reduced cellularity by reducing accumulation of dendritic cells and other lymph-borne contents that may be important in controlling lymph node…”
BackgroundDendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Lee, K.-W., Yam, J. W. P., & Mao, X. (2023) · Cells · doi:10.3390/cells12172147 · Cited by 117
Migration of dendritic cell based cancer vaccines: in vivo veritas?
Adema, G. J., de Vries, I. J. M., Punt, C. J., & Figdor, C. G. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.004 · Cited by 134
Oxidized Phospholipids Negatively Regulate Dendritic Cell Maturation Induced by TLRs and CD40
Blüml, S., Kirchberger, S., Bochkov, V. N., Krönke, G., Stuhlmeier, K. M., Majdic, O., Zlabinger, G. J., Knapp, W., Binder, B. R., Stöckl, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.501 · Cited by 146
“It has been shown that down-regulation of CCR7 results in failure of DC to emigrate from the inflamed tissue to the lymph node (53).”
Sant, A. J., Chaves, F. A., Jenks, S. A., Richards, K. A., Menges, P. R., Weaver, J. M., & Lazarski, C. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00307.x · Cited by 146
Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles
Coutant, F., & Miossec, P. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.147 · Cited by 134
Lymph Node Stromal Cells Support Dendritic Cell-Induced Gut-Homing of T Cells
Molenaar, R., Greuter, M., van der Marel, A. P. J., Roozendaal, R., Martin, S. F., Edele, F., Huehn, J., Förster, R., O'Toole, T., Jansen, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900311 · Cited by 130
Banchereau, J., Ueno, H., Dhodapkar, M. V., Connolly, J., Finholt, J. P., Klechevsky, E., Blanck, J.-P., Johnston, D. A., Palucka, K., & Fay, J. W. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000171292.79663.cb · Cited by 130
“migrate into draining lymph nodes is likely to affect the T-cell priming.(42) DC migration is governed, together with other factors, by the expression of CCR7, a chemokine receptor indicative of the capacity of DCs to respond to appropriate ligands such as CCL19 and CCL21(43,44) expressed in lymphatic tissues.”
BackgroundPrete, A. D., Shao, W.-H., Mitola, S. M. F., Santoro, G., Sozzani, S., & Haribabu, B. (2006) · Blood · doi:10.1182/blood-2006-02-003665 · Cited by 136
Cancer relapse under chemotherapy: Why TLR2/4 receptor agonists can help
Garay, R. P., Viens, P., Bauer, J., Normier, G., Bardou, M., Jeannin, J., & Chiavaroli, C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.018 · Cited by 145
dos Santos, G. G., Reinders, J., Ouwehand, K., Rustemeyer, T., Scheper, R. J., & Gibbs, S. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.02.004 · Cited by 128
Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein
de Noronha, S. (2005) · Blood · doi:10.1182/blood-2004-06-2332 · Cited by 121
Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances
Randolph, G. J., Sánchez‐Schmitz, G., & Angeli, V. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0168-0 · Cited by 146
“Mice deficient in CCR7 show few DCs in lymph nodes [21], and adoptive transfer of CCR7 DCs into wild-type mice confirms that CCR7 expressed by DCs per se is required for emigration to lymph nodes via the lymphatic route [48].”
BackgroundVaccination with Messenger RNA (mRNA)
Pascolo, S. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-72167-3_11 · Cited by 126
“Two general improvements for the DC-based vaccines have been tested: (i) the pretreatment of the DC-injection site with inflammatory cytokines ( Martin-Fontecha et al., 2003 ), and (ii) the direct intralymphatic injection (Grover et al., 2006).”
MethodInflammation, Lymphatic Function, And Dendritic Cell Migration
Angeli, V., & Randolph, G. J. (2006) · Lymphatic Research and Biology · doi:10.1089/lrb.2006.4406 · Cited by 124
“60 However, as these conclusions were drawn by an immunostaining approach that is semiquantitative at best, the regulation of CCL21 on lymphatics by inflammatory signals remains an open question.”
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
Wang, X., Wang, F., Zhong, M., Yarden, Y., & Fu, L. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01200-x · Cited by 139
“The influence of TGF-β on DCs impairs their migratory ability and decreases the expression of costimulatory molecules (CD86/80) [49, 50].”
The innate immune response in leprosy
Modlin, R. L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.12.001 · Cited by 140
“This instructive role of the innate immune system is primarily mediated by DCs, professional antigen-presenting cells [87] that are highly efficient in activation of T cell responses that provide CMI against the pathogen [88].”
Human Lymphatic Endothelial Cells Express Multiple Functional TLRs
Pegu, A., Qin, S., Fallert Junecko, B. A., Nisato, R. E., Pepper, M. S., & Reinhart, T. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3399 · Cited by 120
“Thus CCL20 expressed by afferent LECs could contribute to the trafficking of multiple cell types and thereby help determine the net effects on cell influx and egress in peripheral tissues and associated draining LNs. Finally, increased production of CCL20 and other chemokines will also comprise an innate immune respon…”
BackgroundInfluentialIdzko, M., Hammad, H., van Nimwegen, M., Kool, M., Vos, N., Hoogsteden, H. C., & Lambrecht, B. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28949 · Cited by 124
“A reduction in DC numbers in the MLNs of iloprost-treated mice could result from a reduction in lung inflammation and concomitant reduction in DC influx into the node (29).”
BackgroundPredicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models
Kronik, N., Kogan, Y., Elishmereni, M., Halevi-Tobias, K., Vuk‐Pavlović, S., & Agur, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015482 · Cited by 131
Lymph Node T Cell Homeostasis Relies on Steady State Homing of Dendritic Cells
Wendland, M., Willenzon, S., Kocks, J. R., Davalos‐Misslitz, A. C. M., Hammerschmidt, S. I., Schumann, K., Kremmer, E., Sixt, M., Hoffmeyer, A., Pabst, O., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.017 · Cited by 131
“Along the same line, DCs differentiated from bone marrow of Ccr7-deficient mice do not migrate to the draining LN after subcutaneous injection or intratracheal instillation (Hintzen et al., 2006; Martin-Fontecha et al., 2003; Ohl et al., 2004).”
BackgroundKuan, E. L., Ivanov, S., Bridenbaugh, E. A., Victora, G., Wang, W., Childs, E. W., Platt, A. M., Jakubzick, C. V., Mason, R. J., Gashev, A. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500221 · Cited by 121
“It is clear that enhancing or dampening the number of lymphmigratory DCs bearing Ag impacts the quality and character of an ongoing immune response (19, 44, 45).”
Kidney dendritic cells: fundamental biology and functional roles in health and disease
Kurts, C., Ginhoux, F., & Panzer, U. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0272-y · Cited by 126
Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8
Feijoó, E., Alfaro, C., Mazzolini, G., Serra, P., Peñuelas, I., Arina, A., Huarte, E., Tirapu, I., Palencia, B., Murillo, O., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21046 · Cited by 119
“, tumor tissue, to secondary lymphoid organs are the CCR7 ligands, MIP-3 (ELC) and 6-C-kine (SLC).(24) We found that DCs can be retained by supernatants of colon cancer cells diminishing their response to MIP-3 in classical chemotaxis assays (Fig.”
BackgroundLeucocyte trafficking via the lymphatic vasculature—mechanisms and consequences
Jackson, D. G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00471 · Cited by 120
“Leucocyte-Induced Chemokine Release Synthesis of CCL21 is markedly upregulated in murine and human lymphatic endothelium in response to inflammation (35, 66, 131) whereby the chemokine accumulates in intracellular storage vesicles in readiness for secretion, notably at the basolateral surface of the endothelium where…”
BackgroundDendritic cell vaccines in melanoma: From promise to proof?
Lesterhuis, W. J., Aarntzen, E. H. J. G., de Vries, I. J. M., Schuurhuis, D. H., Figdor, C. G., Adema, G. J., & Punt, C. J. A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.007 · Cited by 124
“[123] MartIn-Fontecha A, Sebastiani S, Hopken UE, et al.”
BackgroundMaturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes
Manfredi, A. A., Capobianco, A., Esposito, A., De Cobelli, F., Canu, T., Monno, A., Raucci, A., Sanvito, F., Doglioni, C., Nawroth, P. P., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2270 · Cited by 115
“Conversely, DC migration abates in mice lacking lymph node chemokines or the -isoform of phosphoinositide-3 kinase, which is required for response to chemotactic agonists (3, 4).”
BackgroundChyou, S., Benahmed, F., Chen, J., Kumar, V., Tian, S., Lipp, M., & Lu, T. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101724 · Cited by 120
Self-citationObesity but not high-fat diet impairs lymphatic function
García Nores, G. D., Cuzzone, D. A., Albano, N. J., Hespe, G. E., Kataru, R. P., Torrisi, J. S., Gardenier, J. C., Savetsky, I. L., Aschen, S. Z., Nitti, M. D., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.96 · Cited by 116
“(27 , 58) These findings are in-line with previous studies demonstrating decreased CCL21 gradients and increased LEC ICAM-1 expression in response to contact hypersensitivity.”
Dendritic Cell Migration to Peripheral Lymph Nodes
Martin‐Fontecha, A., Lanzavecchia, A., & Sallusto, F. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_2 · Cited by 132
“This model is based primarily on observations of the migration of Langerhans cells (LCs) following administration of skin-sensitizing agents ( Macatonia et al. 1987 ), carcinogens, or upon infection (Dandie et al. 1994; Merad et al. 2000).”
BackgroundSelf-citationSchmid, M., Glasner, D. R., Shah, S. B., Michlmayr, D., Kramer, L. D., & Harris, E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005676 · Cited by 123
“Related to Fig 4, frequency of MigDCs, neutrophils, and monocytes as well as number of classical DCs in LNs.Mice were inoculated i.d. with PBS or 105 PFU DENV under 1° or ADE conditions in the presence or absence of SGE, and skin-draining LNs were analyzed via flow cytometry after 14 h. (A) Histogram overlays of surfa…”
BackgroundInfluentialExploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Maisel, K., Sasso, M. S., Potin, L., & Swartz, M. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.005 · Cited by 113
Chemoattractants and their receptors in homeostasis and inflammation
Sallusto, F., & Mackay, C. R. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.012 · Cited by 129
Self-citationDendritic Cell Migration Through the Lymphatic Vasculature to Lymph Nodes
Platt, A. M., & Randolph, G. J. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00002-8 · Cited by 122
Hauser, M. A., Schaeuble, K., Kindinger, I., Impellizzieri, D., Krueger, W. A., Hauck, C. R., Boyman, O., & Legler, D. F. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.010 · Cited by 114
Dendritic cells, pro‐inflammatory responses, and antigen presentation in a rodent malaria infection
Langhorne, J., Albano, F. R., Hensmann, M., Sanni, L. A., Cadman, E. T., Voisine, C., & Sponaas, A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00182.x · Cited by 118
“After encounter with a danger/maturation signal, DCs undergo maturation and migrate to the secondary lymphoid organs, where they efficiently present antigen and stimulate T cells (24, 25).”
BackgroundLymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis
Pei, G., Yao, Y., Yang, Q., Wang, M., Wang, Y., Wu, J., Wang, P., Li, Y., Zhu, F., Yang, J., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw5075 · Cited by 112
The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics
Johnson, L. A., & Jackson, D. G. (2013) · Journal of Cell Science · doi:10.1242/jcs.135343 · Cited by 101
Modulators of arginine metabolism support cancer immunosurveillance
Capuano, G., Rigamonti, N., Grioni, M., Freschi, M., & Bellone, M. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-1 · Cited by 113
“Treatment with L-NAME does not perturb tumor-draining lymph node cell composition Lymph nodes draining a tumor mass (TDLN) or the site of vaccination rapidly enlarge owing to the accumulation of myeloid and lymphoid cells [35,36].”
Lim, Y. T., Noh, Y., Han, J. H., Cai, Q., Yoon, K., & Chung, B. H. (2008) · Small · doi:10.1002/smll.200800582 · Cited by 111
Functional Inactivation of Immature Dendritic Cells by the Intracellular Parasite Toxoplasma gondii
McKee, A. S., Dzierszinski, F. S., Boes, M. L., Roos, D. S., & Pearce, E. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2632 · Cited by 105
“Moreover, by infecting immature DC, parasites may be able to disseminate from the site of infection within cells undergoing steady-state migration to draining lymphoid organs (63, 64).”
BackgroundManzo, A., Bugatti, S., Caporali, R. F., Prevo, R., Jackson, D. G., Uguccioni, M., Buckley, C. D., Montecucco, C., & Pitzalis, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061275 · Cited by 117
Self-citationCell Traffic and the Lymphatic Endothelium
Johnson, L. A., & Jackson, D. G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.011 · Cited by 101
Wiskott–Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells
Calle, Y., Chou, H., Thrasher, A. J., & Jones, G. E. (2004) · The Journal of Pathology · doi:10.1002/path.1651 · Cited by 95
“We do not know yet why maturation leads to podosome loss: unpublished data from our laboratory have confirmed that mature DCs contain abundant WASP and that active Cdc42 (and Rac) can be used to generate filopodia and ruffles in mature cells [28]; nevertheless, we have been unable to regenerate podosomes in matured DC…”
BackgroundInfluentialKohler, R. E., Comerford, I., Townley, S. L., Haylock‐Jacobs, S., Clark‐Lewis, I., & McColl, S. R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00154.x · Cited by 111
“The chemokine receptor CCR7 and its ligands CCL19/ELC and CCL21/SLC play a central role in maintaining the homeostatic trafficking and positioning of both DC and T cells within the peripheral lymphoid tissue (8, 30, 36).”
BackgroundMethodInfluentialThe Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity
Vingert, B., Adotévi, O., Patin, D., Jung, S., Shrikant, P. A., Freyburger, L., Eppolito, C., Sapoznikov, A., Amessou, M., Quintin‐Colonna, F., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535443 · Cited by 107
“Furthermore, after injection only a small amount of the injected DC inoculum is found in the draining lymph node, where the immune response is initiated [ 11 , 12].”
BackgroundTryptophan degradation in autoimmune diseases
Opitz, C. A., Wick, W., Steinman, L., & Platten, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7140-9 · Cited by 118
Lesterhuis, W. J., de Vries, I. J. M., Schuurhuis, D. H., Boullart, A. C. I., Jacobs, J. F. M., de Boer, A. J., Scharenborg, N. M., Brouwer, H., van de Rakt, M. W. M. M., Figdor, C. G., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl072 · Cited by 108
“If the migration efficiency of these low numbers of DCs can be improved, this response may be further enhanced [27].”
BackgroundSynthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes
St. John, A. L., Chan, C. Y., Staats, H. F., Leong, K. W., & Abraham, S. N. (2012) · Nature Materials · doi:10.1038/nmat3222 · Cited by 98
“However, the trafficking of these cells to the draining LN, their subsequent interactions with LN-resident lymphocytes and the activation and interactions of lymphocytes themselves are also essential to the amplification of adaptive immunity and the formation of protective immunological memor”
Human Dendritic Cell Subsets for Vaccination
Dubsky, P. C., Ueno, H., Piqueras, B., Connolly, J., Banchereau, J., & Palucka, K. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8216-7 · Cited by 115
“This in turn significantly increased DC migration to the draining lymph nodes and the magnitude of the CD4+ T-cell response (105).”
BackgroundMoingeon, P. E. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.03.013 · Cited by 106
Jin, H., Qian, Y., Dai, Y., Qiao, S., Huang, C., Lu, L., Luo, Q., Chen, J., & Zhang, Z. (2016) · Theranostics · doi:10.7150/thno.15102 · Cited by 99
“a 10-fold increase in the number of DCs that reached the LNs [8].”
BackgroundLymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases
Zhang, F., Zarkada, G., Yi, S., & Eichmann, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00509 · Cited by 108
Nonredundant role of CCRL2 in lung dendritic cell trafficking
Otero, K., Vecchi, A., Hirsch, E., Kearley, J., Vermi, W., Prete, A. D., Gonzalvo-Feo, S., Garlanda, C., Azzolino, O., Salogni, L., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259903 · Cited by 115
Geng, S., Matsushima, H., Okamoto, T., Yao, Y., Lu, R., Page, K., Blumenthal, R. M., Ward, N. L., Miyazaki, T., & Takashima, A. (2013) · Blood · doi:10.1182/blood-2012-07-445197 · Cited by 96
“15%, n 5 4), which was in complete agreement with the reported homing efficiency for CD11c(1) DCs.(25) To examine in vivo APC function, Ly6G(1)/CD11c/MHC II(1) hybrids purified from GM-CSF–supplemented BM culture were pulsed with latex particles coated with OVA protein and then introduced into the thioglycollate-induc…”
BackgroundInfluentialCCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19
Britschgi, M. R., Favre, S., & Luther, S. A. (2010) · European Journal of Immunology · doi:10.1002/eji.200939921 · Cited by 89
Classical Flt3L-dependent dendritic cells control immunity to protein vaccine
Anandasabapathy, N., Feder, R. E., Mollah, S. A., Tse, S., Longhi, M. P., Mehandru, S., de Matos, I. G., Cheong, C., Ruane, D., Brane, L., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131397 · Cited by 96
“CCR7/ mice were bred at The Rockefeller University after purchase from The Jackson Laboratory and are described with respect to defects in the skinderived DC migration (Martín-Fontecha et al., 2003, 2008).”
MethodA hybrid multi-compartment model of granuloma formation and T cell priming in Tuberculosis
Marino, S., El-Kebir, M., & Kirschner, D. E. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.03.022 · Cited by 101
“rates to a concept known as ‘lymph node shut-down’, a transient, proportional accumulation of all T cell subsets in a lymph node draining a site of inflammation (Cahill et al., 1976; Hall and Morris, 1965; MartIn-Fontecha et al., 2003): higher T cell LN emigration rates (larger x1 and x2 rates) translate into decrease…”
CD4 + T cells support cytotoxic T lymphocyte priming by controlling lymph node input
Kumamoto, Y., Mattei, L. M., Sellers, S., Payne, G. W., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100567108 · Cited by 96
“S5D), indicating that DCs are both required and sufficient to induce dLN hyperplasia, consistent with previous studies (24, 25).”
ResultDistinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes
Muraille, É., Giannino, R., Guirnalda, P. D., Leiner, I. M., Jung, S., Pamer, E. G., & Lauvau, G. S. (2005) · European Journal of Immunology · doi:10.1002/eji.200526024 · Cited by 95
Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells
Cauley, L. S., & Lefrançois, L. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.96 · Cited by 93
Influence of circadian clocks on adaptive immunity and vaccination responses
Ince, L. M., Barnoud, C., Lutes, L. K., Pick, R., Wang, C., Sinturel, F., Chen, C.-S., de Juan, A., Weber, J., Holtkamp, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35979-2 · Cited by 98
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice
Baumjohann, D., Heß, A., Budinský, L., Brune, K., Schuler, G., & Lutz, M. B. (2006) · European Journal of Immunology · doi:10.1002/eji.200535742 · Cited by 103
Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells
Bouma, G., Burns, S. O., & Thrasher, A. J. (2007) · Blood · doi:10.1182/blood-2007-06-096875 · Cited by 93
Long, C. M., van Laarhoven, H. W. M., Bulte, J. W. M., & Levitsky, H. I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3691 · Cited by 99
“The numbers of DCs that ultimately end up in the T-cell zone have been shown to determine the magnitude of T-cell proliferation and effector response (5).”
BackgroundDendritic-cell vaccines on the move
Sabado, R. L., & Bhardwaj, N. (2015) · Nature · doi:10.1038/nature14211 · Cited by 90
The Resistance Mechanisms of Lung Cancer Immunotherapy
Wang, F., Wang, S., & Zhou, Q. H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568059 · Cited by 98
“Transforming growth factor-β (TGF-β) is a cytokine playing key roles in angiogenesis and immunosuppression by stimulating Tregs (207) and excluding T cell in peritumoral fibroblasts (123, 159).”
BackgroundInfluentialOkada, N., Mori, N., Koretomo, R., Okada, Y., Nakayama, T., Yoshie, O., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Mayumi, T., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302358 · Cited by 90
D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion
Lee, K. M., McKimmie, C. S., Gilchrist, D. S., Pallas, K. J., Nibbs, R. J., Garside, P., McDonald, V., Jenkins, C., Ransohoff, R., Liu, L., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344044 · Cited by 87
Voigtländer, C., Röner, S., Cierpka, E., Theiner, G., Wiethe, C., Menges, M., Schuler, G., & Lutz, M. B. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000210081.60178.b4 · Cited by 98
“Preinjection of mature DC or TNF has been shown to improve the migration to the draining lymph nodes of a subsequent DC injection and improves the T-cell response.(15) We used this method here to yield higher numbers of our migrated DC in the lymph node.”
MethodA two‐step model for Langerhans cell migration to skin‐draining LN
Villablanca, E. J., & Mora, J. R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838919 · Cited by 104
Brown, M. N., Fintushel, S. R., Lee, M. H., Jennrich, S., Geherin, S. A., Hay, J. B., Butcher, E. C., & Debes, G. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000676 · Cited by 87
“An extended role for CCR7 in lymphocyte exit from inflamed extralymphoid tissues is supported by studies demonstrating that CCL21 expression is upregulated in lymphatic endothelial cells under inflammatory conditions in vitro (25) and in vivo (26, 27).”
Exercise training improves obesity‐related lymphatic dysfunction
Hespe, G. E., Kataru, R. P., Savetsky, I. L., García Nores, G. D., Torrisi, J. S., Nitti, M. D., Gardenier, J. C., Zhou, J., Yu, J. Z., Jones, L. W., et al. (2016) · The Journal of Physiology · doi:10.1113/jp271757 · Cited by 82
Kole, A., He, J., Rivollier, A., Silveira, D. D., Kitamura, K., Maloy, K. J., & Kelsall, B. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301093 · Cited by 86
Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy
Thomas, S. N., Rohner, N. A., & Edwards, E. E. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-101515-014413 · Cited by 94
“Lymph-migrating dendritic cells also direct the remodeling of the lymph node fibroblastic reticular network after immunogenic challenge (41), and the extent of cellular remodeling of the lymph node interstitium is proportional to the number of mature lymph-transported dendritic cells (42).”
BackgroundVaahtomeri, K., Brown, M., Hauschild, R., De Vries, I., Leithner, A. F., Mehling, M., Kaufmann, W. A., & Sixt, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.027 · Cited by 86
“It might provide local guidance or act as a landmark for following DCs, which have been shown to intravasate with increased efficiency (MartIn-Fontecha et al., 2003).”
Saraiva, A. L., Veras, F. P., Peres, R. S., Talbot, J., de Lima, K. A., Luiz, J. P. M., Carballido, J. M., Cunha, T. M., Cunha, F. Q., Ryffel, B., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800285 · Cited by 97
Lewis, J. S., Stewart, J. M., Marshall, G. P., Carstens, M. R., Zhang, Y., Dolgova, N. V., Xia, C., Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., et al. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00332 · Cited by 89
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Zhang, S.-N., Choi, I.-K., Huang, J.-H., Yoo, J. Y., Choi, K., & Yun, C. (2011) · Molecular Therapy · doi:10.1038/mt.2011.29 · Cited by 86
Mechanisms Involved in Radiation Enhancement of Intratumoral Dendritic Cell Therapy
Teitz‐Tennenbaum, S., Li, Q., Okuyama, R., Davis, M. A., Sun, R., Whitfield, J. R., Knibbs, R. N., Stoolman, L. M., & Chang, A. E. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318163628c · Cited by 90
“The number of antigen-carrying DCs that reach the draining lymph node has been shown to correlate with the potency of the elicited T-cell response.(37) Active retention of IT administered DCs by cancer cell-derived IL-8 has been reported.”
Bonneau, M., Epardaud, M., Payot, F., Niborski, V., Thoulouze, M., Bernex, F., Charley, B., Riffault, S., Guilloteau, L. L. A., & Schwartz-Cornil, I. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605288 · Cited by 86
“This increased number of DC that reach lymph node may further enhance the efficiency of immune response by increasing the efficiency of naive T cell scanning, thus impacting on T cell priming [25].”
BackgroundA Perspective on Cell Tracking with Magnetic Particle Imaging
Sehl, O. C., Gevaert, J. J., Melo, K. P., Knier, N. N., & Foster, P. J. (2020) · Tomography · doi:10.18383/j.tom.2020.00043 · Cited by 98
A DNA/DMXAA/Metal–Organic Framework Activator of Innate Immunity for Boosting Anticancer Immunity
Chen, X., Tang, Q., Wang, J., Zhou, Y., Li, F., Xie, Y., Wang, X., Du, L., Li, J., Pu, J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210440 · Cited by 98
Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Fransen, M. F., Arens, R., & Melief, C. J. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27755 · Cited by 89
The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues
Devi, K. S. P., & Anandasabapathy, N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0602-0 · Cited by 92
Cho, J. J., Stewart, J. M., Drashansky, T. T., Brusko, M., Zuniga, A. N., Lorentsen, K. J., Keselowsky, B. G., & Avram, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.029 · Cited by 86
“Unfortunately, adoptive DC therapy is limited by high cost, inadequate cell sources, and safety concerns [66, 72].”
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.